- A new study from Case Western Reserve University School of Medicine reveals that popular diabetes and weight-loss drugs, Wegovy and Ozempic, may significantly reduce alcohol misuse and alcohol use disorder.
- The research highlights the potential of semaglutide, the active ingredient in these medications, to serve as a new treatment for alcohol-use disorder, a condition responsible for about 178,000 deaths annually in the United States.
- While the findings are promising, experts agree that…
Read the full article here